EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bioactive components and clinical potential of Astragalus species

Shuo Li, Xunpeng Hu, Fen Liu, Weiming Hu

Frontiers in Pharmacology · 16.05.2025 · 16

DOI: 10.3389/fphar.2025.1585697 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 16.05.2025. Verfasst von Shuo Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gansu Phamaceutical Industry Innovation Research Institute, Key Laboratory of Quality and Standard of TCM of Gansu Province, Gansu University of Chin…. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astragalus L., the world’s largest vascular plant genus, has been used medicinally and as food for centuries, especially in traditional Chinese medicine It is widely applied in immune modulation, antioxidant therapy, anti-inflammatory treatments, and antitumor applications. Recent studies show that Astragalus species is rich in bioactive compounds, such as polysaccharides, flavonoids, saponins, alkaloids, and simple phenolics, which demonstrate significant pharmacological effects, including anti-inflammatory, antioxidant, immunomodulatory, and antitumor properties, along with potential benefits for Alzheimer’s disease and diabetes. This review synthesizes 140 references to analyze 51 newly identified flavonoids, 31 triterpenoid saponins, and 19 alkaloids in Astragalus (2020–2025), focusing on their chemical structures and bioactivities. It also examines Astragalus species in medicine and food homology (MFH) and how processing methods affect its efficacy. Furthermore, the mechanisms behind its anti-inflammatory, antioxidant, immune-boosting, antitumor, neuroprotective, and hypoglycemic effects are discussed. Future studies should prioritize large-scale clinical trials to confirm Astragalus ’s efficacy and safety, explore combination therapies, and improve sustainable resource utilization to expand its medical and food applications. Keywords: Bioactive molecules, Astragalus , Pharmacological action, Mechanism of action, Medicine and food homology (MFH).

Schlagwörter

Stichwörter der Autor:innen

Astragalusbioactive moleculesmechanism of actionmedicine and food homology (MFH)pharmacological action

Autor:innen und Institutionen

  • Gansu Phamaceutical Industry Innovation Research Institute, Key Laboratory of Quality and Standard of TCM of Gansu Province, Gansu University of Chinese Medicine, Lanzhou, China.
  • College of pharmacy, Gansu University of Chinese Medicine, Lanzhou, China.
  • Jiangxi Provincial Key Laboratory of Plant Germplasm Resources Innovation and Genetic Improvement, Lushan Botanical Garden, Jiangxi Province and Chinese Academy of Sciences, Jiujiang, China.
  • Jiangxi Academy of Forestry, Nanchang, China.

Zitieren

APA

Li, S., Hu, X., Liu, F., & Hu, W. (2025). Bioactive components and clinical potential of Astragalus species. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1585697

Vancouver

Li S, Hu X, Liu F, Hu W. Bioactive components and clinical potential of Astragalus species. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1585697

BibTeX
@article{Li2025,
  author = {Li, Shuo and Hu, Xunpeng and Liu, Fen and Hu, Weiming},
  title = {Bioactive components and clinical potential of Astragalus species},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1585697}
}
Kostenlos starten →